Novolog Pharm-Up 1966 Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was ILS 309.656 million compared to ILS 267.265 million a year ago. Operating income was ILS 16.937 million compared to ILS 13.272 million a year ago. Net income was ILS 10.119 million compared to ILS 9.118 million a year ago. Basic earnings per share from continuing operations was ILS 0.02 compared to ILS 0.02 a year ago. Diluted earnings per share from continuing operations was ILS 0.02 compared to ILS 0.019 a year ago. For the half year, sales was ILS 625.730 million compared to ILS 569.387 million a year ago. Operating income was ILS 36.094 million compared to ILS 31.615 million a year ago. Net income was ILS 22.978 million compared to ILS 22.520 million a year ago. Basic earnings per share from continuing operations was ILS 0.046 compared to ILS 0.049 a year ago. Diluted earnings per share from continuing operations was ILS 0.045 compared to ILS 0.048 a year ago.